(Q48839913)

English

Pro-gastrin-releasing peptide as a factor predicting the incidence of brain metastasis in patients with small cell lung carcinoma with limited disease receiving prophylactic cranial irradiation.

scientific article published in August 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/15973666

Pro-gastrin-releasing peptide as a factor predicting the incidence of brain metastasis in patients with small cell lung carcinoma with limited disease receiving prophylactic cranial irradiation. (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/15973666

lung small cell carcinoma

1 reference

based on heuristic

inferred from title

brain metastasis

1 reference

based on heuristic

inferred from title

7

object named as

Hiroshi Ikeda

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/15973666

4

object named as

Yoshinori Ito

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/15973666

1

object named as

Kan Yonemori

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/15973666

author name string

Minako Sumi

2

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/15973666

Naoko Fujimoto

3

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/15973666

Atsushi Imai

5

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/15973666

Yoshikazu Kagami

6

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/15973666

language of work or name

0 references

publication date

1 August 2005

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/15973666

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/15973666

104

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/15973666

4

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/15973666

811-816

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/15973666

Enzyme-linked immunosorbent assay of pro-gastrin-releasing peptide for small cell lung cancer patients in comparison with neuron-specific enolase measurement.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21238

21 January 2018

Pro-gastrin-releasing peptide (31-98) as a tumour marker of small-cell lung cancer: comparative evaluation with neuron-specific enolase

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21238

21 January 2018

Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21238

7 January 2021

based on heuristic

inferred from DOI database lookup

Competing events determining relapse-free survival in limited small-cell lung carcinoma. The French Cancer Centers' Lung Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21238

7 January 2021

based on heuristic

inferred from DOI database lookup

Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21238

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylactic Cranial Irradiation for Patients With Small-Cell Lung Cancer in Complete Remission

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21238

7 January 2021

based on heuristic

inferred from DOI database lookup

Intracranial metastases in small cell carcinoma of the lung prognostic aspects

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21238

7 January 2021

based on heuristic

inferred from DOI database lookup

Proceedings: Frequency, diagnosis, and treatment of brain metastases in 247 consecutive patients with bronchogenic carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21238

7 January 2021

based on heuristic

inferred from DOI database lookup

The palliation of brain metastases: Final results of the first two studies by the radiation therapy oncology group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21238

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of prophylactic cranial irradiation in prevention of central nervous system metastases in small cell lung cancer. Potential benefit restricted to patients with complete response

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21238

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized combined modality trial in small cell carcinoma of the lung comparison of combination chemotherapy-radiation therapy versus cyclophosphamide-radiation therapy effects of maintenance chemotherapy and prophylactic whole brain irradiation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21238

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylactic irradiation in bronchogenic small cell anaplastic carcinoma. A comparative trial of localized versus extensive radiotherapy including prophylactic brain irradiation in patients receiving combination chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21238

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicentre randomised trial. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) and the European

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21238

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21238

7 January 2021

based on heuristic

inferred from DOI database lookup

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21238

7 January 2021

based on heuristic

inferred from DOI database lookup

Practice guideline on prophylactic cranial irradiation in small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21238

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum pro-gastrin-releasing peptide is a useful marker for treatment monitoring and survival in small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21238

7 January 2021

based on heuristic

inferred from DOI database lookup

Practice guideline for the role of combination chemotherapy in the initial management of limited-stage small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21238

7 January 2021

based on heuristic

inferred from DOI database lookup

Small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21238

7 January 2021

based on heuristic

inferred from DOI database lookup

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21238

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictive and prognostic factors in small cell lung cancer: current status.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21238

7 January 2021

based on heuristic

inferred from DOI database lookup

Ten-year follow-up of Southwest Oncology Group 8269: a phase II trial of concomitant cisplatin-etoposide and daily thoracic radiotherapy in limited small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21238

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.21238

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/15973666

release_nf66e3cbtfaklg6uyveidczlfm

1 reference

https://api.fatcat.wiki/v0/release/nf66e3cbtfaklg6uyveidczlfm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/15973666

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48839913&oldid=1844461802"